Associations of EPHB1 polymorphisms with hepatocellular carcinoma in the Korean population

Human Immunology

Volumn 72, Issue 10, 2011, Pages 916-920

  Kim, Su Kang ^a   Jeon, Jung Won ^b   Park, Jae Jun ^b   Cha, Jae Myung ^b   Joo, Kwang Ro ^b   Lee, Joung Il ^b   Chung, Joo Ho ^a   Shin, Dong Hoon ^c   Shin, Hyun Phil ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Keimyung University School of Medicine   (South Korea)

Author keywords

Angiogenesis; EPHB1; Hepatocellular carcinoma; Polymorphism

Indexed keywords

EPHRIN RECEPTOR B1; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, EPHB1; REPUBLIC OF KOREA; RISK FACTORS;

EID: 80052971096     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.06.014     Document Type: Article

References (25)

1. Cheng N., Brantley D.M., Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 2002, 13:75-85.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
3. Flanagan J.G., Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci 1998, 21:309-345.
4. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992, 9:383-391.
5. Martinez A., Soriano E. Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res Brain Res Rev 2005, 49:211-226.
6. Davis S., Gale N.W., Aldrich T.H., Maisonpierre P.C., Lhotak V., Pawson T., et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 1994, 266:816-819.
7. Holland S.J., Gale N.W., Mbamalu G., Yancopoulos G.D., Henkemeyer M., Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 1996, 383:722-725.
8. Henkemeyer M., Itkis O.S., Ngo M., Hickmott P.W., Ethell I.M. Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. J Cell Biol 2003, 163:1313-1326.
9. Adams R.H., Wilkinson G.A., Weiss C., Diella F., Gale N.W., Deutsch U., et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999, 13:295-306.
10. Gerety S.S., Anderson D.J. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 2002, 129:1397-1410.
11. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 1997, 90:403-404. Eph Nomenclature Committee.
12. Wang H.U., Chen Z.F., Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93:741-753.
13. Daniel T.O., Stein E., Cerretti D.P., St John P.L., Robert B., Abrahamson D.R. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int 1996, 57(Suppl):S73-S81.
14. Nakamura R., Kataoka H., Sato N., Kanamori M., Ihara M., Igarashi H., et al. EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci 2005, 96:42-47.
15. Davalos V., Dopeso H., Castaño J., Wilson A.J., Vilardell F., Romero-Gimenez J., et al. EPHB4 and survival of colorectal cancer patients. Cancer Res 2006, 66:8943-8948.
16. Wang J., Kataoka H., Suzuki M., Sato N., Nakamura R., Tao H., et al. Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 2005, 24:5637-5647.
17. Clevers H., Batlle E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res 2006, 66:2-5.
18. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421-430.
19. Ueno S., Tanabe G., Nuruki K., Hamanoue M., Komorizono Y., Oketani M., et al. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res 2002, 24:395-403.
20. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
21. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
22. Jung K.H., Ban J.Y., Kim H.J., Park H.J., Uhm Y.K., Kim S.K., et al. Genetic association study of THRB polymorphisms with obesity in Korean population. Mol Cell Toxicol 2008, 4:124-131.
23. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
24. El-Serag H.B., Davila J.A., Petersen N.J., McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817-823.
25. Bralet M.P., Régimbeau J.M., Pineau P., Dubois S., Loas G., Degos F., et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000, 32:200-204.